Literature DB >> 1311980

Establishment and characterization of a panel of human lung cancer cell lines.

B G Campling1, A C Haworth, H M Baker, D L Greer, J J Holden, E C Bradley, J Pym, D F Dexter.   

Abstract

The establishment and characterization of 11 human lung cancer cell lines are described in this article. Nine of these cell lines were established over a 5-year period, from 1983 to 1988, from patients treated at the Kingston Regional Cancer Centre. These include eight definite or probable small cell lung cancer (SCLC) lines and one adenocarcinoma line. In addition, two other SCLC cell lines were characterized. All of the lines have been in continuous culture for more than 2 years. The clinical histories of the patients from whom the cell lines were derived are outlined here. Several features of the cell lines are presented, including the following: (1) a comparison of the histologic features of the cell lines with the original biopsy specimens; (2) the expression of various markers, including cytokeratin, carcinoembryonic antigen, calcitonin, and neuron-specific enolase; (3) activities of the enzymes l-dopa decarboxylase and the brain isoenzyme of creatine kinase; (4) growth characteristics; (5) cloning efficiency in soft agar; (6) tumorigenicity in nude mice; and (7) cytogenetic studies. These cell lines, obtained directly from patients with a spectrum of drug-sensitive and drug-resistant tumors, will be valuable in vitro models of sensitivity and resistance to chemotherapy in lung cancer.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1311980     DOI: 10.1002/1097-0142(19920415)69:8<2064::aid-cncr2820690811>3.0.co;2-#

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Choline transporter-like protein 4 (CTL4) links to non-neuronal acetylcholine synthesis.

Authors:  Pingfang Song; Stephen S Rekow; Corey-Ayne Singleton; Harmanjatinder S Sekhon; Gregory A Dissen; Minerva Zhou; Barbara Campling; Jon Lindstrom; Eliot R Spindel
Journal:  J Neurochem       Date:  2013-06-25       Impact factor: 5.372

2.  The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer.

Authors:  M Cecilia Crisanti; Africa F Wallace; Veena Kapoor; Fabian Vandermeers; Melissa L Dowling; Luana P Pereira; Kara Coleman; Barbara G Campling; Zvi G Fridlender; Gary D Kao; Steven M Albelda
Journal:  Mol Cancer Ther       Date:  2009-08-11       Impact factor: 6.261

3.  Do glutathione and related enzymes play a role in drug resistance in small cell lung cancer cell lines?

Authors:  B G Campling; K Baer; H M Baker; Y M Lam; S P Cole
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

4.  In Silico Oncology: Quantification of the In Vivo Antitumor Efficacy of Cisplatin-Based Doublet Therapy in Non-Small Cell Lung Cancer (NSCLC) through a Multiscale Mechanistic Model.

Authors:  Eleni Kolokotroni; Dimitra Dionysiou; Christian Veith; Yoo-Jin Kim; Jörg Sabczynski; Astrid Franz; Aleksandar Grgic; Jan Palm; Rainer M Bohle; Georgios Stamatakos
Journal:  PLoS Comput Biol       Date:  2016-09-22       Impact factor: 4.475

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.